Literature DB >> 26892531

Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis.

Yuya Matsue1, Atsushi Shiraishi2, Nobuyuki Kagiyama3, Kazuki Yoshida4, Teruyoshi Kume5, Hiroyuki Okura6, Makoto Suzuki7, Akihiko Matsumura7, Kiyoshi Yoshida3, Yuji Hashimoto7.   

Abstract

Although intravenous diuretics have been mainstay drugs in patients with acute heart failure (AHF), they have been suggested to have some deleterious effects on prognosis. We postulated that renal function may modify their deleterious effects in AHF patients. The study population consisted of 1094 AHF patients from three hospitals. Renal dysfunction (RD) was defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 on admission, and the cohort was divided into a high-dose furosemide (≥100 mg/48 h) and low-dose furosemide group according to the amount of intravenous furosemide used within 48 h from admission. In the whole cohort, in-hospital mortality rate was higher in the high-dose furosemide group than the low-dose furosemide group (12.5 vs. 6.6 %, respectively, P = 0.001). However, this difference in the in-hospital mortality rates was significant only in the RD subgroup (15.6 vs. 7.0 %, respectively, P < 0.001), and not in the non-RD subgroup (2.5 vs. 5.9 %, respectively, P = 0.384). Propensity score-matched analysis was performed to evaluate the impact of high-dose furosemide on prognosis. After propensity score matching, high-dose furosemide was not associated with in-hospital mortality (OR 1.25, 95 % CI 0.73-2.16, P = 0.408). However, there was a qualitative difference in OR for in-hospital mortality between AHF with RD (OR 1.77, 95 % CI 0.96-3.28, P = 0.068) and without RD (OR 0.23, 95 % CI 0.05-1.10, P = 0.064), and there was a significant interaction between eGFR and prognostic impact of high-dose furosemide (P for OR interaction = 0.013). An inverse relationship was observed between eGFR and OR for in-hospital death in the group treated with high-dose furosemide (decreasing OR with better eGFR). The deleterious effect of diuretics was significantly modified with renal function in AHF. This association may be one reason for poorer prognosis of AHF patients complicated with renal impairment.

Entities:  

Keywords:  Acute heart failure; Diuretics; Prognosis; Renal function

Mesh:

Substances:

Year:  2016        PMID: 26892531     DOI: 10.1007/s00380-016-0817-y

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  35 in total

1.  Critical issue in the cardiovascular field: Hospitalization for heart failure.

Authors:  Naoki Sato
Journal:  J Cardiol       Date:  2013-06-29       Impact factor: 3.159

2.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  Circulation       Date:  2013-06-05       Impact factor: 29.690

3.  Risk stratification after hospitalization for decompensated heart failure.

Authors:  G Michael Felker; Jeffrey D Leimberger; Robert M Califf; Michael S Cuffe; Barry M Massie; Kirkwood F Adams; Mihai Gheorghiade; Christopher M O'Connor
Journal:  J Card Fail       Date:  2004-12       Impact factor: 5.712

4.  Diuretic strategies in patients with acute decompensated heart failure.

Authors:  G Michael Felker; Kerry L Lee; David A Bull; Margaret M Redfield; Lynne W Stevenson; Steven R Goldsmith; Martin M LeWinter; Anita Deswal; Jean L Rouleau; Elizabeth O Ofili; Kevin J Anstrom; Adrian F Hernandez; Steven E McNulty; Eric J Velazquez; Abdallah G Kfoury; Horng H Chen; Michael M Givertz; Marc J Semigran; Bradley A Bart; Alice M Mascette; Eugene Braunwald; Christopher M O'Connor
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

Review 5.  Epidemiology of heart failure in Asia.

Authors:  Yasuhiko Sakata; Hiroaki Shimokawa
Journal:  Circ J       Date:  2013-08-14       Impact factor: 2.993

6.  Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease.

Authors:  Roberta Poletti; Giuseppe Vergaro; Luc Zyw; Concetta Prontera; Claudio Passino; Michele Emdin
Journal:  Int J Cardiol       Date:  2012-03-28       Impact factor: 4.164

7.  Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis.

Authors:  Mehmet Birhan Yilmaz; Etienne Gayat; Reda Salem; Johan Lassus; Maria Nikolaou; Said Laribi; John Parissis; Ferenc Follath; W Franck Peacock; Alexandre Mebazaa
Journal:  Eur J Heart Fail       Date:  2011-11       Impact factor: 15.534

8.  Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.

Authors:  Robert J Mentz; Susanna R Stevens; Adam D DeVore; Anuradha Lala; Justin M Vader; Omar F AbouEzzeddine; Prateeti Khazanie; Margaret M Redfield; Lynne W Stevenson; Christopher M O'Connor; Steven R Goldsmith; Bradley A Bart; Kevin J Anstrom; Adrian F Hernandez; Eugene Braunwald; G Michael Felker
Journal:  JACC Heart Fail       Date:  2014-10-31       Impact factor: 12.035

9.  Blood urea nitrogen/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure.

Authors:  Meredith A Brisco; Steven G Coca; Jennifer Chen; Anjali Tiku Owens; Brian D McCauley; Stephen E Kimmel; Jeffrey M Testani
Journal:  Circ Heart Fail       Date:  2013-01-16       Impact factor: 8.790

Review 10.  Cardiorenal syndrome in acute decompensated heart failure.

Authors:  Mohammad Sarraf; Amirali Masoumi; Robert W Schrier
Journal:  Clin J Am Soc Nephrol       Date:  2009-11-19       Impact factor: 8.237

View more
  8 in total

1.  Effect of carperitide on in-hospital mortality of patients admitted for heart failure: propensity score analyses.

Authors:  Masataka Ogiso; Toshiaki Isogai; Yuta Okabe; Kansuke Ito; Masaki Tsuji; Hiroyuki Tanaka
Journal:  Heart Vessels       Date:  2017-02-20       Impact factor: 2.037

2.  Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis.

Authors:  Miho Fukui; Takeshi Tsujino; Shinichi Hirotani; Hiroshi Ito; Kazuhiro Yamamoto; Takashi Akasaka; Yutaka Hirano; Nobuyuki Ohte; Takashi Daimon; Satoshi Nakatani; Masaaki Kawabata; Tohru Masuyama
Journal:  Heart Vessels       Date:  2017-01-19       Impact factor: 2.037

3.  Inferior vena cava diameter in acute decompensated heart failure as predictor of all-cause mortality.

Authors:  Alexander Jobs; Kerstin Brünjes; Alexander Katalinic; Valentin Babaev; Steffen Desch; Michael Reppel; Holger Thiele
Journal:  Heart Vessels       Date:  2017-01-23       Impact factor: 2.037

4.  Impact of decreased serum albumin levels on acute kidney injury in patients with acute decompensated heart failure: a potential association of atrial natriuretic peptide.

Authors:  Yoichi Takaya; Fumiki Yoshihara; Hiroyuki Yokoyama; Hideaki Kanzaki; Masafumi Kitakaze; Yoichi Goto; Toshihisa Anzai; Satoshi Yasuda; Hisao Ogawa; Yuhei Kawano; Kenji Kangawa
Journal:  Heart Vessels       Date:  2017-02-07       Impact factor: 2.037

5.  Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study.

Authors:  Yoshitaka Okuhara; Shinichi Hirotani; Tomotaka Ando; Koichi Nishimura; Yoshiyuki Orihara; Kazuo Komamura; Yoshiro Naito; Toshiaki Mano; Tohru Masuyama
Journal:  Heart Vessels       Date:  2016-07-28       Impact factor: 2.037

6.  Administration of tolvaptan with reduction of loop diuretics ameliorates congestion with improving renal dysfunction in patients with congestive heart failure and renal dysfunction.

Authors:  Akihisa Hanatani; Atsushi Shibata; Ryouko Kitada; Shinichi Iwata; Yoshiki Matsumura; Atsushi Doi; Kenichi Sugioka; Masahiko Takagi; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2016-07-06       Impact factor: 2.037

7.  Persistent high blood urea nitrogen level is associated with increased risk of cardiovascular events in patients with acute heart failure.

Authors:  Kentaro Jujo; Yuichiro Minami; Shintaro Haruki; Yuya Matsue; Kensuke Shimazaki; Hiromu Kadowaki; Issei Ishida; Keigo Kambayashi; Hiroyuki Arashi; Haruki Sekiguchi; Nobuhisa Hagiwara
Journal:  ESC Heart Fail       Date:  2017-06-27

8.  Temporal trends in tolvaptan use after revision of national heart failure guidelines in Japan.

Authors:  Yusuke Yamazaki; Yasuyuki Shiraishi; Shun Kohsaka; Yuji Nagatomo; Keiichi Fukuda; Takashi Kohno; Tsutomu Yoshikawa
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.